Welcome to the


Advance the Greek Scientific Paradigm

Greek Scientists Society 2nd Symposium

Discover the way a Greek Scientific Paradigm may develop an “Innovation Ecosystem 5.0”Sunday, October 31, 2021 14:00 EET

The Greek Scientist Society GSS is an Initiative by

What we do

The Post-COVID World “New Normal”

Humanity is entering unprecedented technological and socio-cultural changes that will lead to the advent of a new paradigm with major structural changes, shifting even further from digital to hybrid virtual transformation.

We aspire to pave the brave new world by facilitating and nurturing the new business and especially those in Research with deep tech innovation disruptions and where applicable, digital twin technologies in various verticals while we will enable our members to take advantage of AI-solutions.

By establishing the Greek Scientists Society we wish to develop the necessary tools and provide the necessary means for the Greek and Cypriot Scientists to successfully implement their Research and then market their results.

Although we are field agnostic and we invite Scientists from all disciplines, we focus at first on the Biomed sector with the establishment of the Hellenic Biomed Network  and on the IT sector with the Hellenic Infotech Network

Meet our Team

Theo Zacharis

Innovation & Strategy Advisor

Our Scientific Advisory Board

Prof George Chrousos

Professor of Pediatrics and Endocrinology Emeritus, NKUA School of Medicine. UNESCO Chair on Adolescent Health Care

Prof Elias

Professor of Science, Technology, Innovation and Entrepreneurship, Director, GWUSB European Union Research Center

Prof George Vassiliou

Professor George Professor of Haematological Medicine - University of Cambridge, Wellcome-MRC Cambridge Stem Cell Institute

Dr Evi

Adjunct Professor at the School of Public and Environmental Affairs - Indiana University at Bloomington

Dr Panteli Theocharous

Global Vice President Cell Gene Therapy, PPD

Why Join Greek Scientists Society

Linkedin Members

Our Sponsors

Strategic Partners

Wish To Contact Us?

Drop Us A Line And Keep In Touch

Join our Linkedin Group

Subscribe to our Channels

Prof George Chrousos

George P. Chrousos, MD, ScD born in Patras, Greece, is a Greek-American pediatrician, endocrinologist, neurobiologist and one of the world’s foremost medical clinical researchers. He serves as Professor of Pediatrics and Endocrinology Emeritus at the National and Kapodistrian University of Athens School of Medicine, Athens, Greece and as Director of University Research Institute of Maternal And Child Health & Precision Medicine

He currently also holds the UNESCO Chair on Adolescent Health Care. He is one of the 250 most cited scientists internationally (ISI highly cited), included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and is the highest cited Clinical Pediatrician or Endocrinologist in the world. 

Professor Elias Carayannis

Dr. Elias G. Carayannis is Full Professor of Science, Technology, Innovation and Entrepreneurship, as well as
co-Founder and co-Director of the Global and Entrepreneurial Finance Research Institute (GEFRI) and
Director of the European Union Research Center, (EURC) at the School of Business of the George
Washington University in Washington, DC.
Dr. Carayannis’ teaching and research activities focus on the areas of strategic Government-University-Industry R&D partnerships, technology road-mapping, technology transfer and commercialization, international science and technology policy, technological entrepreneurship and regional economic development.

Prof George Vassiliou

George Vassiliou is a Greek Cypriot graduated from the Royal London Hospital Medical College in 1994.He is Professor of Haematological Medicine, University of Cambridge.

He is also CR-UK Senior Clinical Fellow and a member of Faculty at the Wellcome Sanger and Wellcome-MRC Cambridge Stem Cell Institutes. His group is studying the pre-clinical evolution, pathogenesis and treatment of haematological malignancies with a particular focus on acute myeloid leukaemia (AML).

He is also a Consultant Haematologist at Addenbrooke’s Hospital in Cambridge where he treats patients with haematological cancers.

Dr Evi Hatziandreou

Dr. Evi Hatziandreou is a Health Care, Research & Innovation Consultant, a graduate of Athens Medical School holds a joint Doctoral Degree in Health Policy and Management & Epidemiology from the Harvard School of Public Health. She was a Lecturer at the Department of Health Policy and Management, Harvard School of Public Health, and as Fellow of the American Association for the Advancement of Science.

She is teaching as Adjunct Professor at the School of Public and Environmental Affairs, of Indiana University at Bloomington.

She is serving as the Scientific Advisor at DIKTIO, Network for Reform in Greece & Europe.

Dr Panteli Theocharous

Dr. Panteli Theocharous is Global Vice President, Cell and Gene therapy strategy lead at PPD.

As a senior-level industry executive in prior CMO roles and a cancer immunotherapy expert, he has led multiple hematology/oncology assets in clinical development
including innovative immuno-oncology technologies and successful life cycle management, MAA/NDA and HTA submissions.

Leader in delivering transformational patient-centric solutions that prolong and improve cancer patient lives. Executive-level Client Consultation and a non-executive director (NED).